Skip to main content

TEVA 7767 (Everolimus 5 mg)

Pill with imprint TEVA 7767 is White, Elliptical / Oval and has been identified as Everolimus 5 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; pancreatic cancer; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7767

Everolimus

Imprint
TEVA 7767
Strength
5 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Mtor inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Pliva Hrvatska d.o.o.
National Drug Code (NDC)
00093-7767

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.